Given the multiple in vitro studies documenting the antagonistic effect of IL-17RD on mitogenic signaling pathways and cell proliferation, it is tempting to speculate that the protein may exert its tumor suppressor function by curtailing cancer cell proliferation. Here, IL17RD is linked to cancer.